Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial

Author:

Shimizu Yasuhiro12,Yoshikawa Toshiaki1,Kojima Takashi3,Shoda Kayoko1,Nosaka Kazuto1,Mizuno Shoichi1,Wada Satoshi4,Fujimoto Yuki4,Sasada Tetsuro4ORCID,Kohashi Kenichi5,Bando Hideaki3ORCID,Endo Itaru2,Nakatsura Tetsuya1ORCID

Affiliation:

1. Division of Cancer Immunotherapy Exploratory Oncology Research and Clinical Trial Center National Cancer Center Kashiwa Japan

2. Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan

3. Department of Gastroenterology National Cancer Center Hospital East Kashiwa Japan

4. Division of Cancer Immunotherapy Kanagawa Cancer Center Research Institute Yokohama Japan

5. Department of Anatomic Pathology Pathological Science Kyusyu University Graduate School of Medicine Fukuoka Japan

Funder

Japan Agency for Medical Research and Development

National Cancer Center

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3